Write You - Real Estate

Basic Comparison

You can compare different mortgage offers by eval

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

uating some basic factors:

loan size
loan rate
closing cost

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

loan term

time of offer

Loan Size When c

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

omparing offers from different lenders you should make sure you are comparing loans

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

f the same size.

Closing Costs

Some lenders may quote you differe

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

t ways - such as with a closing cost and no closing cost options. You can't compare

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

an offer from one lender to another if one offer has no closing costs and another lo

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

n does. Most lenders can offer loans either way, and change their rates and closing

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

costs to conform to your requests.

Loan Term

Lenders may also quo

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

e you loans that are for different time periods. You can't compare the terms and rat

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

for a 15 year loan with a 40 year loan. Lenders price these loans differently.

Eve

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

n similar sounding loans can have different loan terms. For example, a minimum payme

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

t option loan may have similar terms, but they will be very different if one lender

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

has a term of 30 years and another lender offers 40 year terms.

The 40 year term wi

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

l offer substantially lower minimum payment options than a 30 year term, even though

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

both the loans are called "minimum payment option" loans.

Time of Offer
ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust
trong>

Interest rates change each day, and some lenders can change mortgage rates t
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
roughout the day. Comparing an offer from one lender made on Tuesday with another le
.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
nder's offer made on Friday is not helpful to you. One lender might look cheaper tha
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip
the other only because the day they were quoting the loan interest rates were lower

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Write You - Figuring Out Which Lender Is Better

Related Articles: